267 related articles for article (PubMed ID: 24260801)
21. Intralesional steroid in the era of propranolol for infantile hemangioma-Do we need it?
Pandey A; Srivastava A; Pant N; Singh S; Rawat J
J Plast Reconstr Aesthet Surg; 2023 Feb; 77():117-122. PubMed ID: 36566639
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and Management of Infantile Hemangiomas in the Neonate.
Harter N; Mancini AJ
Pediatr Clin North Am; 2019 Apr; 66(2):437-459. PubMed ID: 30819347
[TBL] [Abstract][Full Text] [Related]
23. Surgical Intervention of Periocular Infantile Hemangiomas in the Era of β-Blockers.
Men CJ; Ediriwickrema LS; Paik JS; Murdock J; Yen MT; Ng JD; Liu CY; Korn BS; Kikkawa DO
Ophthalmic Plast Reconstr Surg; 2020; 36(1):70-73. PubMed ID: 31809485
[TBL] [Abstract][Full Text] [Related]
24. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis.
Chinnadurai S; Fonnesbeck C; Snyder KM; Sathe NA; Morad A; Likis FE; McPheeters ML
Pediatrics; 2016 Feb; 137(2):e20153896. PubMed ID: 26772662
[TBL] [Abstract][Full Text] [Related]
26. Hemangiomas treated with propranolol: do the rewards outweigh the risks?
Haider KM; Neely DE; Plager DA
Am Orthopt J; 2013; 63():2-5. PubMed ID: 24260800
[TBL] [Abstract][Full Text] [Related]
27. Propranolol versus steroids for the treatment of ulcerated infantile hemangiomas.
Polites SF; Rodrigue BB; Chute C; Hammill A; Dasgupta R
Pediatr Blood Cancer; 2018 Oct; 65(10):e27280. PubMed ID: 29932302
[TBL] [Abstract][Full Text] [Related]
28. Comparison of intralesional corticosteroid and propranolol treatment of periorbital infantile hemangiomas: an outcome study of 61 cases.
Hoornweg MJ; Saeed P; Tanck MW; Hage JJ; Coumou AD; Van Der Horst CM
Eur J Ophthalmol; 2014; 24(6):940-7. PubMed ID: 24729139
[TBL] [Abstract][Full Text] [Related]
29. Periocular infantile hemangiomas: Characteristics, ocular sequelae, and outcomes.
Zhao J; Huang AH; Rainer BM; Kryatova MS; Eghrari AO; Wang J; Puttgen KB; Cohen BA
Pediatr Dermatol; 2019 Nov; 36(6):830-834. PubMed ID: 31448460
[TBL] [Abstract][Full Text] [Related]
30. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol.
Sondhi V; Patnaik SK
J Pediatr Hematol Oncol; 2013 Oct; 35(7):493-9. PubMed ID: 23929318
[TBL] [Abstract][Full Text] [Related]
31. Propranolol therapy for reducing the number of nasal infantile hemangioma invasive procedures.
Perkins JA; Chen BS; Saltzman B; Manning SC; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2014 Mar; 140(3):220-7. PubMed ID: 24557492
[TBL] [Abstract][Full Text] [Related]
32. Propranolol for the treatment of infantile haemangiomas: our experience with 44 patients.
Lynch M; Lenane P; O'Donnell BF
Clin Exp Dermatol; 2014 Mar; 39(2):142-5. PubMed ID: 24289272
[TBL] [Abstract][Full Text] [Related]
33. [Infantile hemangioma: update and treatment].
Léauté-Labrèze C
Arch Pediatr; 2013 May; 20(5):517-22. PubMed ID: 23474035
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
Thoumazet F; Léauté-Labrèze C; Colin J; Mortemousque B
Br J Ophthalmol; 2012 Mar; 96(3):370-4. PubMed ID: 21673014
[TBL] [Abstract][Full Text] [Related]
35. Retrospective case series of increased oral propranolol dosage for infantile hemangiomas.
Huang AH; Mannschreck D; Aggarwal P; Mahon M; Cohen BA
Pediatr Dermatol; 2020 Nov; 37(6):1057-1062. PubMed ID: 32869385
[TBL] [Abstract][Full Text] [Related]
36. Propranolol Treatment of Vascular Anomalies Other Than Infantile Hemangioma.
Goss JA; Konczyk DJ; Alomari MH; Maclellan RA; Greene AK
J Craniofac Surg; 2017 Nov; 28(8):2001-2003. PubMed ID: 28968329
[TBL] [Abstract][Full Text] [Related]
37. Indications for surgical resection of complicated infantile hemangiomas in the β-blocker's era: a single-institution experience from a retrospective cohort study.
Beqo BP; Gasparella P; Flucher C; Spendel S; Quehenberger F; Haxhija EQ
Int J Surg; 2023 Apr; 109(4):829-840. PubMed ID: 36974689
[TBL] [Abstract][Full Text] [Related]
38. Infantile haemangioma: part II. Risks, complications and treatment.
Léauté-Labrèze C; Prey S; Ezzedine K
J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1254-60. PubMed ID: 21569113
[TBL] [Abstract][Full Text] [Related]
39. Treatment of infantile haemangiomas: recommendations of a European expert group.
Hoeger PH; Harper JI; Baselga E; Bonnet D; Boon LM; Ciofi Degli Atti M; El Hachem M; Oranje AP; Rubin AT; Weibel L; Léauté-Labrèze C
Eur J Pediatr; 2015 Jul; 174(7):855-65. PubMed ID: 26021855
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
